×
English
हिंदी
ગુજરાતી
Home
My Feed
Remove Ads
Get Premium Content
Go Pro @₹99
Loan Against Mutual Fund
Apply Now
Credit Cards
Instant Loans
Apply Now
Credit Score
Refer & Earn ₹500
Refer Now
Finance Tracker
Learning Curve
Fixed Deposits
Business Loan
Vouchers
Markets
Markets
FII & DII Activity
Corporate Action
Research Advice
Earnings
Technical Trends
Stock Deals
Intraday Large Deals
Bonds
Webinar
Pre Market
Stock Scanner
Sector Analysis
Unlisted Shares
Stock Updates
PRO Stock Lists
Monsoon Tracker
Seasonality Analysis
Crypto Dashboard
Web Stories
Tax Calculator
Forum
Gold Rate
Silver Rate
IFSC Code Finder
Storyboard18
IPO
Economic Indicators
Economic Calendar
Global Markets
US Markets
ETFs
Indian Indices
News
News
Tech/Startups
Auto
Research
Opinion
Politics
Personal Finance
EPF Guide
Real Estate
Portfolio
Watchlist
Personal Finance
Personal Finance
Loans
Fixed Deposit Comparison
Fixed Deposit Interest Calculator
Moneycontrol - SecureNow Health Insurance ratings
Mutual Funds
Mutual Funds
Performance Tracker
Top ranked funds
My Portfolio
Top performing Categories
Forum
New Fund Offers
MF Simplified
Commodities
Mutual Funds
Gold Rate
Silver Rate
Currencies
Cryptocurrency
Media
Live TV & Shows
Video
Podcast
Photos
Invest Now
Trade like Experts
Invest in Unlisted Shares
Specials
Pharma Industry Conclave
Unlocking opportunities in Metal and Mining
#MFSummit2025
Advanced Technical Charts
International
Get App
Be a
Pro
Home
PRO
Markets
News
Budget 2026
Editor’s Picks
Tech
India
Learning Curve
Portfolio
Watchlist
Commodities
MF
PF
Forum
Videos
you are here:
Home
News
Johnson And Johnson
Johnson And Johnson
‘Not able to sell, what next’: Chemist body asks Johnson and Johnson as FDA orders withdrawal of baby powder from market
'Withdraw baby powder from the market': Maharashtra FDA tells J&J
J&J’s move to exit talc globally need not raise any fresh concerns
Dear Johnson & Johnson, are babies in India of a lesser god?
Johnson & Johnson won’t take controversial baby powder off shelves in India
60 million COVID doses gone waste in US: A blot on pharma industry
New analyses show Johnson & Johnson’s one-dose vaccine works well
Delhi HC stays order asking J&J to deposit over Rs 230cr profit from sale of baby products
Delhi HC stays penalty notice on Johnson and Johnson for 'profiteering' on sale of sanitary napkins
Pharma wrap: J&J in news again Australian court rules against company over pelvic mesh lawsuit
Delhi HC asks J&J to pay Rs 25 Lakh to 67 patients who had revision surgery for faulty hip implants
SC closes case against Johnson & Johnson for faulty hip implants
J&J faulty implant victims allege lack of transparency in deciding compensation, threaten boycott
Medical experts seek formation of a national joint replacement registry
J&J case: Govt asks 'victims' to approach central or state panel
Johnson & Johnson suppressed key facts of the faulty hip replacements sold in India: Report
J&J plans to expand tuberculosis R&D in India
J&J working with Indian govt on tuberculosis treatment
States begin testing J&J baby products for cancer-causing agents
Strides Shasun gets CCI nod to buy 7 brands of J&J
Dishman gets licence from J&J to make TB drug raw material
Sun Pharma dips 2% as J&J signs agreement to produce Doxil
Sun Pharma hits record high, CLSA says buy post Doxil issue
Sun Pharma may get windfall gains on cancer drug Doxil
J&J to resume ops at Mulund plant after HC reprieve
View More
Home
Markets
Loans
SPIN
2
WIN
News
Portfolio